Clinical Trial Update: Caffeine for Infants Born at 28 to 34 Weeks Receiving Respiratory Support [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial from Queen's University is evaluating caffeine citrate for preterm infants born at 28 to 34 weeks who require respiratory support; the …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Preterm Birth

Drugs mentioned

• Caffeine citrate (caffeine citrate)

Snippet

Sponsor: Queen's University | Conditions: Preterm Birth, Caffeine | Phase 2 | Status: NOT_YET_RECRUITING